Xpress Biologics Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Employees
  • 18
Employees
  • Latest Deal Type
  • Buyout/​LBO
  • Financing Rounds
  • 6

Xpress Biologics General Information

Description

Operator of a contract manufacturing platform intended to provide services for pre-clinical productions. The company's systems include the design of microbial expression services, the development of the upstream and downstream processes and the development of the quality controls for the production of recombinant proteins, antibody fragments and plasmid DNA, enabling the vaccine, therapeutic and diagnostic markets to execute and manage clinical trials.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Discovery
Primary Office
  • Accessia Pharma site
  • Avenue du Parc Industriel, 89, Milmort
  • 4041 Herstal
  • Belgium
+32 04 000 00 00

Xpress Biologics Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Xpress Biologics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Xpress Biologics‘s full profile, request access.

Request a free trial

Xpress Biologics Executive Team (5)

Name Title Board Seat Contact Info
Carola Jüstel Chief Executive Officer
Philippe Ledent Ph.D Co-Founder, Co-Owner, Board Member & Scientific Director
Christian Rodriguez Ph.D Co-Founder, Co-Owner, Operation Director & Board Member
Marc Daukandt Co-Founder, Co-Owner, Executive Director, Chief Business Officer & Board Member
Jürgen Pohle Chairman
To view Xpress Biologics’s complete executive team members history, request access »

Xpress Biologics Board Members (5)

Name Representing Role Since
000000000 000000000 00.0 Xpress Biologics Co-Founder, Co-Owner, Operation Director & Board Member 000 0000
0ü0000 00000 Xpress Biologics Chairman 000 0000
0000 00000000 Xpress Biologics Co-Founder, Co-Owner, Executive Director, Chief Business Officer & Board Member 000 0000
00000000 000000 00.0 Xpress Biologics Co-Founder, Co-Owner, Board Member & Scientific Director 000 0000
0é00 00000000 Xpress Biologics Board Member 000 0000
To view Xpress Biologics’s complete board members history, request access »

Xpress Biologics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Xpress Biologics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Xpress Biologics‘s full profile, request access.

Request a free trial